Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

JUERGENS

Showing results (461-470 of 662) with videos related to

Pageof 67
Sort By:
Current Oncology (Toronto, Ont.)|May 12, 2017
Management of <i>EGFR-</i>mutated non-small-cell lung cancer: practical implications from a clinical and pathology perspectiveM Cabanero, R Sangha, B S Sheffield, et al.
Genes, Chromosomes & Cancer|May 9, 2008
Biological importance of a polymorphic CA sequence within intron 1 of the epidermal growth factor receptor gene (EGFR) in high grade central osteosarcomasChristian Kersting, Konstantin Agelopoulos, Hartmut Schmidt, et al.
Human Vaccines & Immunotherapeutics|March 1, 2014
Safety and immunogenicity of 13-valent pneumococcal conjugate vaccine formulations with and without aluminum phosphate and comparison of the formulation of choice with 23-valent pneumococcal polysaccharide vaccine in elderly adults: a randomized open-label trialChristine Juergens, Pierre J T de Villiers, Keymanthri Moodley, et al.
Pediatric Blood & Cancer|December 26, 2015
Management and Outcome of Ewing Sarcoma of the Head and NeckKnut Grevener, Lianne M Haveman, Andreas Ranft, et al.
Alimentary Pharmacology & Therapeutics|October 18, 2005
Esomeprazole 20 mg vs. pantoprazole 20 mg for maintenance therapy of healed erosive oesophagitis: results from the EXPO studyJ Labenz, D Armstrong, K Lauritsen, et al.
The Pediatric Infectious Disease Journal|July 19, 2017
Safety and Immunogenicity of 13-Valent Pneumococcal Conjugate Vaccine in Children 6-17 Years of Age in India: An Open-label TrialSharad Agarkhedkar, Christine Juergens, Krishnamurthy Balasundaram, et al.
Palliative Medicine|June 15, 2021
Development and validation of a prediction model of poor performance status and severe symptoms over time in cancer patients (PROVIEW+)Hsien Seow, Peter Tanuseputro, Lisa Barbera, et al.
Pediatric Blood & Cancer|August 8, 2018
Impact of the Interdisciplinary Tumor Board of the Cooperative Ewing Sarcoma Study Group on local therapy and overall survival of Ewing sarcoma patients after induction therapyJustus Kreyer, Andreas Ranft, Beate Timmermann, et al.
Medical and Pediatric Oncology|December 7, 2000
Telomerase is a strong indicator for assessing the proneness to progression in neuroblastomasC Poremba, B Hero, B Heine, et al.
The American Journal of Cardiology|March 8, 2011
Evaluation of troponin T criteria for periprocedural myocardial infarction in patients with acute coronary syndromesIbrahim Meloud Shugman, Patrick Diu, Jayesh Gohil, et al.
Pageof 67

Showing results (461-470 of 662) with videos related to

Sort By:
Pageof 67
Current Oncology (Toronto, Ont.)|May 12, 2017
Management of <i>EGFR-</i>mutated non-small-cell lung cancer: practical implications from a clinical and pathology perspectiveM Cabanero, R Sangha, B S Sheffield, et al.
Genes, Chromosomes & Cancer|May 9, 2008
Biological importance of a polymorphic CA sequence within intron 1 of the epidermal growth factor receptor gene (EGFR) in high grade central osteosarcomasChristian Kersting, Konstantin Agelopoulos, Hartmut Schmidt, et al.
Human Vaccines & Immunotherapeutics|March 1, 2014
Safety and immunogenicity of 13-valent pneumococcal conjugate vaccine formulations with and without aluminum phosphate and comparison of the formulation of choice with 23-valent pneumococcal polysaccharide vaccine in elderly adults: a randomized open-label trialChristine Juergens, Pierre J T de Villiers, Keymanthri Moodley, et al.
Pediatric Blood & Cancer|December 26, 2015
Management and Outcome of Ewing Sarcoma of the Head and NeckKnut Grevener, Lianne M Haveman, Andreas Ranft, et al.
Alimentary Pharmacology & Therapeutics|October 18, 2005
Esomeprazole 20 mg vs. pantoprazole 20 mg for maintenance therapy of healed erosive oesophagitis: results from the EXPO studyJ Labenz, D Armstrong, K Lauritsen, et al.
The Pediatric Infectious Disease Journal|July 19, 2017
Safety and Immunogenicity of 13-Valent Pneumococcal Conjugate Vaccine in Children 6-17 Years of Age in India: An Open-label TrialSharad Agarkhedkar, Christine Juergens, Krishnamurthy Balasundaram, et al.
Palliative Medicine|June 15, 2021
Development and validation of a prediction model of poor performance status and severe symptoms over time in cancer patients (PROVIEW+)Hsien Seow, Peter Tanuseputro, Lisa Barbera, et al.
Pediatric Blood & Cancer|August 8, 2018
Impact of the Interdisciplinary Tumor Board of the Cooperative Ewing Sarcoma Study Group on local therapy and overall survival of Ewing sarcoma patients after induction therapyJustus Kreyer, Andreas Ranft, Beate Timmermann, et al.
Medical and Pediatric Oncology|December 7, 2000
Telomerase is a strong indicator for assessing the proneness to progression in neuroblastomasC Poremba, B Hero, B Heine, et al.
The American Journal of Cardiology|March 8, 2011
Evaluation of troponin T criteria for periprocedural myocardial infarction in patients with acute coronary syndromesIbrahim Meloud Shugman, Patrick Diu, Jayesh Gohil, et al.
Pageof 67